Randomized phase II trial of extended versus standard neoadjuvant therapy for esophageal cancer, NCCTG (Alliance) trial N0849
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 4026
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. Alberts G. Soori Q. Shi D. Wigle R. Sticca R. Miller J. Leenstra P. Peller T. Wu H. Yoon T. Drevyanko S. Ko B. Mattar D. Nikcevich R. Behrens M. Khalil G. Kim
- Networks:
- Study
- NCCTG-N0849
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: